Moving off the critical path: Streamlining strategies for drug substance synthesis and manufacturing
Each molecule has unique requirements and challenges, and a variety of solutions for drug substance synthesis and manufacturing are available,…
Quotient Sciences
Latest in
Quotient Sciences
Partner content
Rapidly Accelerate Development Timelines: The Integration of Drug Substance & Drug Product Development
From preclinical through clinical development to commercial products, no other pharmaceutical drug development company offers it all at one organization.…
Partner content
Reducing drug development risks & timeline delays: An Integrated Bioanalytical & Pharmacokinetics (PK) Strategy
Delivering an effective integrated bioanalytical and pharmacokinetics (PK) strategy – in even the most challenging of circumstances. Stuart McDougall, VP…
Partner content
Rapidly Accelerate Development Timelines: The Integration of Drug Substance & Drug Product Development
From preclinical through clinical development to commercial products, no other pharmaceutical drug development company offers it all at one organization.…